Brief: Biomx Announces Closing Of The Acquisition Of Adaptive Phage Therapeutics And Concurrent $50 Million Financing
18/03/2024 10:54
March 18 (Reuters) - Biomx Inc PHGE.A :
* BIOMX ANNOUNCES CLOSING OF THE ACQUISITION OF ADAPTIVE
PHAGE
THERAPEUTICS AND CONCURRENT $50 MILLION FINANCING
* BIOMX INC -FINANCING OF $50 MILLION WILL BE USED TO
ADVANCE TWO
LEAD PRODUCT CANDIDATES THROUGH PHASE 2 CLINICAL READOUTS IN
2025
Source text for Eikon: ID:nGNX79wspW
Further company coverage: PHGE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biomx
See all newsBrief: Biomx Inc - Buys 100% Of Zorronet From Water Io - SEC Filing
Brief: BiomX Obtains Option To Acquire Control Of Israeli Laser-Radar Counter-Drone System
Brief: Biomx Adds Former Mossad Deputy To Advisory Board
Brief: Biomx Inc - Jonathan Solomon Resigns As CEO And Board Member Effective March 4, 2026 - SEC Filing
Brief: BiomX Says Unaware of Any Undisclosed Developments Amid Unusual Stock Trading